Fecal Occult Blood Tests Market Size, Share & Trends [Report]

Global fecal occult blood tests market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.3% in the forecast period of 2023 to 2030 and is expected to reach USD 2,426.86 million by 2030.

"Due to the potential of SWOT analysis and Porter's Five Forces analysis in generating Fecal Occult Blood Tests Market  research reports, these analyzes are preferred by businesses and hence are also used while generating Fecal Occult Blood Tests Market reports. To compile these world-class reports, a combination of the best industry insights, practical solutions, talent solutions and the latest technology has been used. As today's businesses highly demand market research analysis before taking any decision about the product, selecting such market research reports is very important for the business. The DBMR team is committed to presenting promising market reports and how to forecast them.

The international Fecal Occult Blood Tests Market Report offers research and consulting services focused on achieving competitiveness, with gaining and maintaining market position as the main goal of the program. Company profiles of all the key players and brands dominating the Fecal Occult Blood Tests Market have been considered here. This report has broad and comprehensive market insights based on business intelligence. Fecal Occult Blood Tests s Market document includes Compound Annual Growth Rate (CAGR) estimation in % values ​​for the forecast period which will help clients to take decisions based on futuristic charts.

Global fecal occult blood tests market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.3% in the forecast period of 2023 to 2030 and is expected to reach USD 2,426.86 million by 2030.

Explore Further Details about This Research Fecal Occult Blood Tests Market Report https://www.databridgemarketresearch.com/reports/global-fecal-occult-blood-tests-market

REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customisable to 2015-2020)

Quantitative Units

Revenue in USD Million

Segments Covered

By Test Type (Lateral Flow Immuno-Fob Test Kits, Immuno-FOB Agglutination Test Kits, Immuno-FOB ELISA Test Kits, Guaiac FOB Stool Test, Flushable Reagent Pad or Tissue, and Others), Application (Colorectal Cancer Screening, Concern for Gastrointestinal Bleeding, Polyps, Diverticulosis, Ulcers, Haemorrhoids, Colitis, Anemia, and Others), End User (Diagnostic Laboratories, Hospitals, Specialty Clinics, and Others), Distribution Channel (Direct Sales, Retail Sales, E-Commerce, and Others)

Countries Covered

U.S., Canada, Mexico, Russia, Spain, Turkey, Germany, Italy, U.K., France, Belgium, Switzerland, Netherlands, Rest of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel and the Rest of the Middle East and Africa

Market Players Covered

Biopanda Reagents Ltd, HUMASIS.COM, CTK Biotech, Inc., Biohit Oyj, CERTEST BIOTEC, Alfa Scientific Designs, Inc., Cenogenics Corporation, and Jant Pharmacal Corporation., Quidel Corporation, Wondfo., Siemens Healthcare GmbH among others

Market Definition

A fecal occult blood test (FOBT) is a diagnostic screening test performed to analyze hidden (occult) blood in stool samples. The fecal occult blood test is also known as stool occult blood, immunoassay FOBT, hemoccult, and IFOBT and guaiac smear test commonly. The test is majorly utilized to screen colon cancer and analyze possible causes of unexplained anemia.

Fecal Occult Blood Tests Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Rising Cases Of Colorectal Cancer Globally

Colorectal cancer is a disease of the colon or rectum, which are parts of the digestive system. Unlike most cancers, colorectal cancer is often preventable with screening can be treated when detected early. Most cases of colorectal cancer occur in people ages 45 older. The disease is increasingly affecting younger people due to unhygienic lifestyles smoking habits. Colorectal cancers may develop without symptoms. The common symptoms may include blood in or on the stool, persistent unusual bowel movements like constipation or diarrhea, stomach pain, aches or cramps that last longer and losing weight for no reason.

Most colorectal cancers start as abnormal tissue growth, called a polyp, inside the colon or rectum. Doctors can detect polyps with the help of screening tests can remove them from developing into colorectal cancer. Even if it spreads into nearby lymph nodes, chemotherapy surgical treatments are effective ways to treat colorectal cancer. Research is going on to learn more about this disease and provide more hope to people with all stages of colorectal cancer.

  • Direct-to-consumer Laboratory Testing

Direct-to-consumer laboratory testing is an effective way for users where they can order their corresponding laboratory tests directly from a lab without any healthcare providers. Nowadays, the healthcare industry is shifting towards direct-to-consumer laboratory testing from physician-based lab testing hence the demand has increased drastically. Most of the patients are focusing on direct-to-consumer based laboratory tests without going through a lengthy in-clinic process, which is fueling the growth of the fecal occult blood tests market.

For the identification of previously unknown medical disorders, the test results are used. The advancements in the field of direct-to-consumer laboratory testing have become crucial to increase patient engagement for better monitoring screening of existing health conditions. Hence, it is very important for laboratory professionals to upgrade the devices instruments used in testing laboratories.

  • Easy Availability Of Fecal Occult Immunological Test Devices In Online Stores

A fecal occult blood test (FOBT) generally focuses on a stool sample to check for blood. The presence of blood in stool refers that there is bleeding in the digestive tract. The bleeding can be caused by a variety of conditions like Polyps (abnormal growths on the lining of the colon or rectum), Hemorrhoids (swollen veins in the anus or rectum), Diverticulosis (a condition with small pouches in the inside wall of the colon), Ulcers (sores in the lining of the digestive tract), Colitis (a type of inflammatory bowel disease) and Colorectal cancer.

There are a huge number of fecal occult immunological test devices available in the market, and people can buy the kits devices from various online sites. Hence, it can be a driving factor for the growth of the fecal occult blood tests market.

Fecal Occult Blood Tests Market

Opportunities

  • Increase in screening procedures

Most government agencies and scientific societies recommend cervical, breast, and colorectal screening because of the burden of these cancers, the availability of screening tests, and the proven efficacy of screening in reducing mortality, as well as incidence, for cervical and colorectal cancers.

The European Community recommends the implementation of population-based screening programs for colorectal cancers. This recommendation is supported by many observational studies showing that organized programs effectively reduce mortality and control the inappropriate use of screening tests.

  • Rising technical advancements

A blood test has always been a technology- and data-dependent field. As data and technology potentially revolutionized diagnostic services and had positioned to partner with patients, families, practitioners, researchers, industry leaders, policymakers, and administrators to ensure that humanistic, high-value, ever-improving precise diagnosis remains the central goal for the future of blood test diagnosis.

The use of fecal occult blood testing has expanded to several indications, even though its primary use is for evaluating an occult source of GI blood loss and for home-based kits in colorectal carcinoma screening. One of the most common clinical uses for the hemoccult is for checking a stool specimen for occult bleeding prior to anticoagulation.

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2022)
  • Past Pricing and price curve by region (2018 to 2022)
  • Market Size, Share, Size Forecast by different segment | 2023−2029
  • Fecal Occult Blood Tests Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
  • Market Segmentation – A detailed analysis by segment with their sub-segments and Region
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective
  • Competitive landscape – Market Leaders, Market Followers, Regional player
  • Competitive benchmarking of key players by region
  • PESTLE Analysis
  • PORTER’s analysis
  • Value chain and supply chain analysis
  • Legal Aspects of Business by Region
  • Lucrative business opportunities with SWOT analysis
  • Recommendations

Browse Related Reports: 

1-Dodecene Market Value | Size,Trends,Forecast|

Events Services Market Demand,Size ,Share, Industry

Passive infrared sensor Market Size, Analysis and Forecast

Packaging Inserts and Cushions Market Size, Share, Trends Forecast

Mattress Topper Market Size And Share Analysis Report,

Nasal Spray Packaging Market by Size, Share, Forecast, Trends

Paper Cone Market Size Report- Industry Growth Analysis

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com

"


pratik Patil

188 Blog posts

Comments